Dallas

2018 Annual Conference

IHFDA is pleased to announce the dates and location of the 2018 IHFDA annual conference. The dates are October 22-24, 2018, in Dallas, Texas, at the Embassy Suites, Dallas-Frisco Hotel, Convention Center & Spa.

This is an incredible venue and we are looking forward to our third annual conference to be even better than the first two. Look for more information on this website for conference registration and accommodations. Mark your calendar now for this great event.

CE credit information is below.

Click here for the current Agenda – *subject to change

Exhibitor Info

IHFDA has chosen the Embassy Suites, Dallas-Frisco Hotel, Convention Center & Spa, to host the 2018 conference. You are able to make hotel reservations by:

– Using the “Hotel Reservations” button

– Calling the hotel direct at 972.963.9175

– Or using the group code at www.embassysuitesdallasfrisco.com

**Conference group name is “IHFDA 2018 Conference”, and the group code is “IHF”

Conference Speakers (A-Z)

Jeff Andert

Compliance Consultant
Kaiser Permanente
Enterprise Regional Compliance, Care Delivery and Pharmacy

“Pharmacy Investigations at Kaiser Permanente”

SPEAKER BIO

Harry Heinonen

Compliance Consultant
Kaiser Permanente
Enterprise Regional Compliance, Care Delivery and Pharmacy

“Pharmacy Investigations at Kaiser Permanente”

SPEAKER BIO

Karen Lettre

Diversion Specialist, Texas Children’s Hospital

“Developing a Diversion Prevention Program in a Children’s Health System”

SPEAKER BIO

Dennis Luken

Treasurer, IHFDA

“Understanding the Law Enforcement Perspective on Diversion”

SPEAKER BIO

Lauren Lollini

Secretary, IHFDA

“A Victim’s Perspective”

SPEAKER BIO

Jeannell M. Mansur, R.Ph, Pharm.D, FASHP, FSMSO, CJCP

Principal Consultant, Medication Management and Safety
Joint Commission Resources/Joint Commission International

“Medication Management and Diversion”

SPEAKER BIO

Jason Mehr, MPH, CIC

Healthcare Associated Infections Coordinator
Communicable Disease Service
New Jersey Department of Health

“Collaboration Between Public Health and Healthcare Facilities”

Ben Mink

President and CEO, GTC Consulting Inc.

“A Close Encounter: How to Effectively Reduce Controlled Substance Liability- Pre, Mid, & Post DEA Regulatory Action”

SPEAKER BIO

Philip A. Mullenix

John E. Reid and Associates

“The Reid Technique of Investigative Interviewing”

SPEAKER BIO

Aurora Pop-Vicas, MD, MPH

Assistant Professor, Infectious Diseases, Associate Hospital Epidemiologist, University of Wisconsin School of Medicine

“Tampering and Substitution: A Case Study from the University of Wisconsin”

Shabbir Imber Safdar

Executive Director
Partnership of Safe Medicines

“Protecting Patients from Harm Associated with Counterfeit Medications”

SPEAKER BIO

Shawn Parekh, PharmD, MHA, FACHE

National, Chief Pharmacy Officer

Prospect Medical Holdings, Inc

“A Case Study on Diversion, A Culture of Excellence”

SPEAKER BIO

Michele Sheaffer

Assistant Director of Pharmacy

Abington Memorial Hospital

“A Case Study on Diversion, A Culture of Excellence”

SPEAKER BIO

Greg Raymond DNP, MBA, RN, NEA-BC

Vice President of Nursing, University of Maryland Medical Center

“Using Huddles to Improve Diversion Investigations”

SPEAKER BIO

Lisa Robin, MLA

Chief Advocacy Officer at Federation of State Medical Boards

“Role of Medical Boards in Drug Diversion Cases”

SPEAKER BIO

Dr. Lynn Webster, M.D.

“Patient Care in the New Normal-One Physician’s Experience”

SPEAKER BIO

CE Credit Information

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Nurses / Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Internal Health Facility Diversion Association. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 14.25 contact hours for nurses and number of knowledge/application/practice-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.